Guoqiang Cao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Guoqiang Cao has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
Li Li
Department of Respiratory Medicine, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China
4 shared publicationsFenfen Sun
Department of Respiratory and Critical Care Medicine, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing 400042, P.R. China
3 shared publicationsHui Cao
Department of Radiology, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing 400042, P.R. China
2 shared publicationsNaifu Nie
Department of Respiratory Medicine, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China
2 shared publications- Paul W. Jones
11Clinical Research Respiratory, GSK, London, UK
2 shared publications - Xiangyu Ma
Department of Epidemiology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing, 400038, China
2 shared publications
Latest Publications
- Open Access
- 4 March 2025
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 29 (4) , 1-7
Resection of organizing pneumonia with leftover adjacent cystic squamous lung carcinoma: A case report and literature review
The aim of the present case report was to investigate the clinical manifestations, imaging features and changes of tumor markers of organizing pneumonia (OP) complicated by squamous lung carcinoma with cystic air space (LC‑CAS). A patient with OP resection and leftover adjacent LC‑CAS complicated by pneumothorax was evaluated. Relevant reports of OP cases complicated by LC‑CAS before February 2022 were searched in the PubMed, EMBASE, Web of Science, China Biomedical Literature Service System, Wanfang Data, China Journal Network full‑text database and China HowNet databases using ‘lung cancer’ OR ‘lung cancer with cystic air space’ AND ‘organizing pneumonia’ as retrieval terms. After screening relevant reports, no Chinese articles and only one English article (case report) were obtained. The patient in the literature showed signs of dry cough, tachypnea and fever during the early stage of the disease. Chest computed tomography (CT) revealed an irregular consolidation around the lower lobe of the right lung accompanied by a sign of bronchial inflation (usually indicated by a clear bronchial shadow seen in the diseased lung tissue area). A positron emission tomography‑CT (PET‑CT) scan and examination for tumor markers were not performed. OP secondary to LC‑CAS was confirmed by bronchoscopy, and the patient was in a generally good condition 6 months after right lobotomy. The patient in the present case had no obvious discomfort during the early stage of the disease. Chest high‑resolution CT showed that the LC‑CAS had an irregular shape, uneven wall thickness and feeding vessels during the early stage, and cystic cavity consolidation during the later stage of the disease. PET‑CT revealed that the OP exhibited increased 18F‑fluorodeoxyglucose (18F‑FDG) uptake, whereas the LC‑CAS did not exhibit a high 18F‑FDG uptake at the early stage, and that the level of tumor markers (such as neuron‑specific enolase, cytokeratin 19 fragment and squamous cell carcinoma antigen) gradually increased. OP was diagnosed through histopathological examination. A total of 32 months after pulmonary lobectomy, bronchoscopy revealed endobronchial neoplasm, and LC‑CAS was diagnosed through biopsy. In conclusion, the present case demonstrates that OP with LC‑CAS is rare, and thus, prone to missed or delayed diagnosis. Therefore, good clinical judgment and continuous learning can help reduce misdiagnosis.
- 4 March 2025
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 29 (4) , 1-7
Open AccessResection of organizing pneumonia with leftover adjacent cystic squamous lung carcinoma: A case report and literature review
The aim of the present case report was to investigate the clinical manifestations, imaging features and changes of tumor markers of organizing pneumonia (OP) complicated by squamous lung carcinoma with cystic air space (LC‑CAS). A patient with OP resection and leftover adjacent LC‑CAS complicated by pneumothorax was evaluated. Relevant reports of OP cases complicated by LC‑CAS before February 2022 were searched in the PubMed, EMBASE, Web of Science, China Biomedical Literature Service System, Wanfang Data, China Journal Network full‑text database and China HowNet databases using ‘lung cancer’ OR ‘lung cancer with cystic air space’ AND ‘organizing pneumonia’ as retrieval terms. After screening relevant reports, no Chinese articles and only one English article (case report) were obtained. The patient in the literature showed signs of dry cough, tachypnea and fever during the early stage of the disease. Chest computed tomography (CT) revealed an irregular consolidation around the lower lobe of the right lung accompanied by a sign of bronchial inflation (usually indicated by a clear bronchial shadow seen in the diseased lung tissue area). A positron emission tomography‑CT (PET‑CT) scan and examination for tumor markers were not performed. OP secondary to LC‑CAS was confirmed by bronchoscopy, and the patient was in a generally good condition 6 months after right lobotomy. The patient in the present case had no obvious discomfort during the early stage of the disease. Chest high‑resolution CT showed that the LC‑CAS had an irregular shape, uneven wall thickness and feeding vessels during the early stage, and cystic cavity consolidation during the later stage of the disease. PET‑CT revealed that the OP exhibited increased 18F‑fluorodeoxyglucose (18F‑FDG) uptake, whereas the LC‑CAS did not exhibit a high 18F‑FDG uptake at the early stage, and that the level of tumor markers (such as neuron‑specific enolase, cytokeratin 19 fragment and squamous cell carcinoma antigen) gradually increased. OP was diagnosed through histopathological examination. A total of 32 months after pulmonary lobectomy, bronchoscopy revealed endobronchial neoplasm, and LC‑CAS was diagnosed through biopsy. In conclusion, the present case demonstrates that OP with LC‑CAS is rare, and thus, prone to missed or delayed diagnosis. Therefore, good clinical judgment and continuous learning can help reduce misdiagnosis.
- Open Access
Health outcomes of COVID-19 patients from Wuhan, China 3-year after hospital discharge: a cohort study
Objectives To evaluate changes in health outcomes between years 2 and 3 after discharge following COVID-19 and to identify risk factors for poor health 3-year post-discharge. Design This is a multicentre observational cohort study. Setting This study was conducted in two centres from Wuhan, China. Participants Eligibility screening has been performed in 3988 discharged laboratory-confirmed adult COVID-19 patients. Exclusion criteria were refusal to participate, inability to contact and death before follow-up. The WHO COVID-19 guidelines on defining disease severity were adopted. Results 1594 patients participated in the 1-year, 2-year and 3-year follow-ups, including 796 (49.9%) male patients, and 422 (26.5%) patients were classified in the severe disease group. 3 years after discharge, 182 (11.4%) patients still complained of at least one symptom. The most common symptoms were fatigue, myalgia, chest tightness, cough, anxiety, shortness of breath and expectoration. Fatigue or myalgia, the most common symptom cluster, frequently coexisted with chest symptoms and anxiety. Symptom persistence between years 2 and 3 was reported in 70 patients (4.4%) for which intensive care unit (ICU) admission was a risk factor (p=0.038). Of the 1586 patients who completed the chronic obstructive pulmonary disease assessment test (CAT), 97 (6.1%) scored ≥10, with older age being associated with CAT ≥10 (p=0.007). Conclusions Between years 2 and 3 after SARS-CoV-2 infection, most patients returned to an asymptomatic state, and only a few were still symptomatic. ICU admission was a risk factor for symptom persistence.
Open AccessHealth outcomes of COVID-19 patients from Wuhan, China 3-year after hospital discharge: a cohort study
Objectives To evaluate changes in health outcomes between years 2 and 3 after discharge following COVID-19 and to identify risk factors for poor health 3-year post-discharge. Design This is a multicentre observational cohort study. Setting This study was conducted in two centres from Wuhan, China. Participants Eligibility screening has been performed in 3988 discharged laboratory-confirmed adult COVID-19 patients. Exclusion criteria were refusal to participate, inability to contact and death before follow-up. The WHO COVID-19 guidelines on defining disease severity were adopted. Results 1594 patients participated in the 1-year, 2-year and 3-year follow-ups, including 796 (49.9%) male patients, and 422 (26.5%) patients were classified in the severe disease group. 3 years after discharge, 182 (11.4%) patients still complained of at least one symptom. The most common symptoms were fatigue, myalgia, chest tightness, cough, anxiety, shortness of breath and expectoration. Fatigue or myalgia, the most common symptom cluster, frequently coexisted with chest symptoms and anxiety. Symptom persistence between years 2 and 3 was reported in 70 patients (4.4%) for which intensive care unit (ICU) admission was a risk factor (p=0.038). Of the 1586 patients who completed the chronic obstructive pulmonary disease assessment test (CAT), 97 (6.1%) scored ≥10, with older age being associated with CAT ≥10 (p=0.007). Conclusions Between years 2 and 3 after SARS-CoV-2 infection, most patients returned to an asymptomatic state, and only a few were still symptomatic. ICU admission was a risk factor for symptom persistence.
- Open Access
- 10 May 2021
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 21 (1) , 1-4
Multifocal pleural capillary hemangioma: a rare cause of hemorrhagic pleural effusion-case report
Background: Capillary hemangioma can be found in many organs, but rarely in pleura. Previously, only localized pleural capillary hemangioma cases have been reported. Corticosteroids are the most commonly recommended drugs in capillary hemangioma. Case presentation: Here, we present a case of a young woman with recurrent hemorrhagic pleural effusion. Despite repeatedly thoracentesis, the routine examinations, including chest computed tomography (CT) scan, pleural effusion biochemical test, and cytology all failed to make a definite diagnosis. Thus, single port video-assisted thoracoscopy (VATS) was then performed. Numerous nodules arising from the parietal pleura were found, and biopsies showed multifocal pleural capillary. However, recurrent pleural effusion was successfully managed by oral azathioprine, after failure of dexamethasone treatment. Conclusions: To our knowledge, this is the first case of a patient with recurrent hemorrhagic pleural effusion masquerading as malignant pleurisy, but in fact caused by multifocal pleural capillary hemangioma.
- 10 May 2021
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 21 (1) , 1-4
Open AccessMultifocal pleural capillary hemangioma: a rare cause of hemorrhagic pleural effusion-case report
Background: Capillary hemangioma can be found in many organs, but rarely in pleura. Previously, only localized pleural capillary hemangioma cases have been reported. Corticosteroids are the most commonly recommended drugs in capillary hemangioma. Case presentation: Here, we present a case of a young woman with recurrent hemorrhagic pleural effusion. Despite repeatedly thoracentesis, the routine examinations, including chest computed tomography (CT) scan, pleural effusion biochemical test, and cytology all failed to make a definite diagnosis. Thus, single port video-assisted thoracoscopy (VATS) was then performed. Numerous nodules arising from the parietal pleura were found, and biopsies showed multifocal pleural capillary. However, recurrent pleural effusion was successfully managed by oral azathioprine, after failure of dexamethasone treatment. Conclusions: To our knowledge, this is the first case of a patient with recurrent hemorrhagic pleural effusion masquerading as malignant pleurisy, but in fact caused by multifocal pleural capillary hemangioma.
- Open Access
- 9 February 2021
- Published by Impact Journals, LLC in Aging
- Vol. 13 (3) , 3176-3189
Development and validation of a prognostic nomogram for predicting in-hospital mortality of COVID-19: a multicenter retrospective cohort study of 4086 cases in China
To establish an effective nomogram for predicting in-hospital mortality of COVID-19, a retrospective cohort study was conducted in two hospitals in Wuhan, China, with a total of 4,086 hospitalized COVID-19 cases. All patients have reached therapeutic endpoint (death or discharge). First, a total of 3,022 COVID-19 cases in Wuhan Huoshenshan hospital were divided chronologically into two sets, one (1,780 cases, including 47 died) for nomogram modeling and the other (1,242 cases, including 22 died) for internal validation. We then enrolled 1,064 COVID-19 cases (29 died) in Wuhan Taikang-Tongji hospital for external validation. Independent factors included age (HR for per year increment: 1.05), severity at admission (HR for per rank increment: 2.91), dyspnea (HR: 2.18), cardiovascular disease (HR: 3.25), and levels of lactate dehydrogenase (HR: 4.53), total bilirubin (HR: 2.56), blood glucose (HR: 2.56), and urea (HR: 2.14), which were finally selected into the nomogram. The C-index for the internal resampling (0.97, 95% CI: 0.95-0.98), the internal validation (0.96, 95% CI: 0.94-0.98), and the external validation (0.92, 95% CI: 0.86-0.98) demonstrated the fair discrimination ability. The calibration plots showed optimal agreement between nomogram prediction and actual observation. We established and validated a novel prognostic nomogram that could predict in-hospital mortality of COVID-19 patients.
- 9 February 2021
- Published by Impact Journals, LLC in Aging
- Vol. 13 (3) , 3176-3189
Open AccessDevelopment and validation of a prognostic nomogram for predicting in-hospital mortality of COVID-19: a multicenter retrospective cohort study of 4086 cases in China
To establish an effective nomogram for predicting in-hospital mortality of COVID-19, a retrospective cohort study was conducted in two hospitals in Wuhan, China, with a total of 4,086 hospitalized COVID-19 cases. All patients have reached therapeutic endpoint (death or discharge). First, a total of 3,022 COVID-19 cases in Wuhan Huoshenshan hospital were divided chronologically into two sets, one (1,780 cases, including 47 died) for nomogram modeling and the other (1,242 cases, including 22 died) for internal validation. We then enrolled 1,064 COVID-19 cases (29 died) in Wuhan Taikang-Tongji hospital for external validation. Independent factors included age (HR for per year increment: 1.05), severity at admission (HR for per rank increment: 2.91), dyspnea (HR: 2.18), cardiovascular disease (HR: 3.25), and levels of lactate dehydrogenase (HR: 4.53), total bilirubin (HR: 2.56), blood glucose (HR: 2.56), and urea (HR: 2.14), which were finally selected into the nomogram. The C-index for the internal resampling (0.97, 95% CI: 0.95-0.98), the internal validation (0.96, 95% CI: 0.94-0.98), and the external validation (0.92, 95% CI: 0.86-0.98) demonstrated the fair discrimination ability. The calibration plots showed optimal agreement between nomogram prediction and actual observation. We established and validated a novel prognostic nomogram that could predict in-hospital mortality of COVID-19 patients.
- Open Access
- 1 February 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (6) , e18938
Behcet's disease with invasive pulmonary aspergillosis and Aspergillus auriculatus infection A case report
Rationale: Behcet's disease (BD) is an inflammatory disease that leads to multisystemic immune dysfunction and that involves pulmonary system alterations. Patient concerns: A 26-year-old woman presented with dull right chest pain for 30 days and intermittent cough with expectoration for 5 days. She had a history of recurrent oral ulcer and constitutional rash 2 months prior. Diagnoses: The patient was diagnosed with BD complicated by IPA and Aspergillus auriculatus infection. Interventions: The patient was administered itraconazole oral solution (200 mg b.i.d) to treat the fungal infection. After a diagnosis of BD was made, she received 40 mg of methylprednisolone sodium succinate daily for 1 week. Then, she also received 24 mg of methylprednisolone sodium succinate daily, which was decreased by 2 mg per half month, until the rash had resolved. The patient continued to receive 200 mg Q. D itraconazole orally for 3 months. Thereafter, itraconazole was stopped, while daily oral administration of 10 mg of methylprednisolone sodium succinate was continued. Outcomes: The rash was observed to resolve, and CT revealed that the lesions in both the right and left lung were reduced. During a telephone follow-up performed after 6 months, the patient stated that no symptoms had recurred during the follow-up period. Lessons: This case illustrates that for patients with BD, ignoring extrapulmonary symptoms often leads to a delayed diagnosis. Physicians should perform a thorough medical history and physical examination of these patients, as the information obtained in this manner may provide important clues for disease diagnosis and treatment.
- 1 February 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (6) , e18938
Open AccessBehcet's disease with invasive pulmonary aspergillosis and Aspergillus auriculatus infection A case report
Rationale: Behcet's disease (BD) is an inflammatory disease that leads to multisystemic immune dysfunction and that involves pulmonary system alterations. Patient concerns: A 26-year-old woman presented with dull right chest pain for 30 days and intermittent cough with expectoration for 5 days. She had a history of recurrent oral ulcer and constitutional rash 2 months prior. Diagnoses: The patient was diagnosed with BD complicated by IPA and Aspergillus auriculatus infection. Interventions: The patient was administered itraconazole oral solution (200 mg b.i.d) to treat the fungal infection. After a diagnosis of BD was made, she received 40 mg of methylprednisolone sodium succinate daily for 1 week. Then, she also received 24 mg of methylprednisolone sodium succinate daily, which was decreased by 2 mg per half month, until the rash had resolved. The patient continued to receive 200 mg Q. D itraconazole orally for 3 months. Thereafter, itraconazole was stopped, while daily oral administration of 10 mg of methylprednisolone sodium succinate was continued. Outcomes: The rash was observed to resolve, and CT revealed that the lesions in both the right and left lung were reduced. During a telephone follow-up performed after 6 months, the patient stated that no symptoms had recurred during the follow-up period. Lessons: This case illustrates that for patients with BD, ignoring extrapulmonary symptoms often leads to a delayed diagnosis. Physicians should perform a thorough medical history and physical examination of these patients, as the information obtained in this manner may provide important clues for disease diagnosis and treatment.
- 1 June 2018
- Published by Elsevier in Respiratory Medicine
- Vol. 139, 86-90
Adjunctive use of prednisolone in the treatment of free-flowing tuberculous pleural effusion: A retrospective cohort study
- 1 June 2018
- Published by Elsevier in Respiratory Medicine
- Vol. 139, 86-90
Adjunctive use of prednisolone in the treatment of free-flowing tuberculous pleural effusion: A retrospective cohort study
- 22 March 2012
- Published by SAGE Publications in Chronic Respiratory Disease
- Vol. 9 (2) , 77-81
Use of nonprescription medicines by patients with COPD: A survey in Chongqing Municipality, China
To study the impact of self-administration of nonprescription medicines (NPMs) on patients with chronic obstructive pulmonary disease (COPD), in Chongqing Municipality, China. A total of 85 patients who had used NPM were assigned to the NPM group. Another 83 patients who had only used prescription medicines (PMs) were assigned to the PM group. Their income, educational levels, health status, public health insurance coverage, the expense of drugs during exacerbation, and the numbers of acute exacerbations during the past year were surveyed, and the approved drugs for COPD were evaluated. The contents of corticosterone in various types of NPMs were determined by high-performance liquid chromatography. The proportion of use of NPM in hospitalized patients with COPD was 12.96%. The percentage of illiteracy and low income was significantly higher in COPD patients in the NPM group than those in the PM group. The cost of drugs per day and the quality of life in the NPM group were lower than those in the PM group. Further analysis revealed that 15 of 21 NPMs contained corticosteroids. More importantly, medical advice from doctors and nurses appeared to be effective. Some Chinese patients with COPD living in the Chongqing area of China used NPMs that contained corticosteroids. Health education and advisement can effectively limit the use of NPMs.
- 22 March 2012
- Published by SAGE Publications in Chronic Respiratory Disease
- Vol. 9 (2) , 77-81
Use of nonprescription medicines by patients with COPD: A survey in Chongqing Municipality, China
To study the impact of self-administration of nonprescription medicines (NPMs) on patients with chronic obstructive pulmonary disease (COPD), in Chongqing Municipality, China. A total of 85 patients who had used NPM were assigned to the NPM group. Another 83 patients who had only used prescription medicines (PMs) were assigned to the PM group. Their income, educational levels, health status, public health insurance coverage, the expense of drugs during exacerbation, and the numbers of acute exacerbations during the past year were surveyed, and the approved drugs for COPD were evaluated. The contents of corticosterone in various types of NPMs were determined by high-performance liquid chromatography. The proportion of use of NPM in hospitalized patients with COPD was 12.96%. The percentage of illiteracy and low income was significantly higher in COPD patients in the NPM group than those in the PM group. The cost of drugs per day and the quality of life in the NPM group were lower than those in the PM group. Further analysis revealed that 15 of 21 NPMs contained corticosteroids. More importantly, medical advice from doctors and nurses appeared to be effective. Some Chinese patients with COPD living in the Chongqing area of China used NPMs that contained corticosteroids. Health education and advisement can effectively limit the use of NPMs.